| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Gonzalez David Angulo | Chief Executive Officer | 2025-10-17 | 32,500 | $0.76 | $24.70kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Perceptive Advisors LLC | 5.37% | 2,400,000 | $2.24M | Insider |
| Avidity Partners Management LP | 4.66% | 2,081,660 | $1.94M | Institution |
| Goldman Sachs Group Inc 1 | 4.44% | 1,984,561 | $1.85M | Institution |
| Goldman Sachs Group Inc | 4.44% | 1,984,561 | $1.85M | Institution |
| Vanguard Group Inc | 3.95% | 1,762,322 | $1.65M | Institution |
| Sanofi | 3.75% | 1,677,057 | $1.57M | Insider |
| Gonzalez David Angulo | 3.04% | 1,357,126 | $1.27M | Insider |
| Alta Biopharma Partners II LP | 2.88% | 1,286,311 | $1.20M | Insider |
| Acadian Asset Management LLC | 1.31% | 583,114 | $544.63k | Institution |
| Scott Sukenick | 1.29% | 574,539 | $536.62k | Insider |